Manulife will cover specialty drugs at any pharmacy after Loblaw deal backlash
Global News
Manulife Financial has reversed course after initially saying it would transition customers getting specialty drug coverage to fill their prescriptions at Loblaw-owned pharmacies.
Manulife Financial Corp. says patients who require specialty drugs will be able to fill their prescriptions at any pharmacy after backlash sparked by the insurance provider signing an exclusive arrangement with Loblaw Cos. Ltd.
The insurance provider had told patients last month its specialty drug program would transition to being carried out “primarily” through Shoppers Drug Mart and other Loblaw-owned pharmacies. Manulife had previously also covered specialty drugs through national home and community health-care provider Bayshore HealthCare.
“We have listened to and are addressing the concerns we have heard over the past week,” said Manulife Canada chief executive Naveed Irshad in a statement on Monday.
“Though this change impacts only a small number of our members, it helps ensure that all Canadians we support have choice, access, and flexibility in managing their health. We are proud to partner with thousands of pharmacies across the country and contribute to a strong and healthy Canadian healthcare system.”
Manulife’s specialty drug program affects around 260 medications meant to treat complex, chronic or life-threatening conditions such as rheumatoid arthritis, Crohn’s, multiple sclerosis, pulmonary arterial hypertension, cancer, osteoporosis and hepatitis C.
Patients covered under the program represent less than one per cent of all those insured through Manulife, the company said, adding that “across the rest of our business, we have always offered Canadians the option to choose their pharmacy.”
Deals that provide exclusivity for a particular pharmacy to distribute drugs under an insurance plan are known as preferred pharmacy network arrangements. Researchers have said those arrangements are common in the U.S. and growing in Canada.
Manulife had previously said the shift to an exclusive agreement would give patients “more options” to receive their specialty medications, with patients able to pick up drugs from a Loblaw-owned pharmacy or have them delivered to their home.
The motion won't mean the city is investing or accepting payment in cryptocurrency any time soon, but will instead direct staff to look into those possibilities.
Enbridge officials said in a statement that the reroute proposal has gone through rigorous reviews and studies.
A proposed deal that would see three tobacco giants pay out billions to provinces and territories, as well as smokers across Canada, has been approved by the companies' creditors.
Tokyo recently announced a four-day workweek policy in an effort to boost Japan’s record-low fertility rate - something that Canada is also struggling with.
More than 1,500 firefighters were battling the blaze, many working in steep canyons, according to the California Department of Forestry and Fire Protection, known as Cal Fire.
Evidence has grown in recent years that highly processed foods are linked to a wide range of chronic health problems, like diabetes and heart disease.
Environment and Climate Change Canada has released its list of the top 10 most impactful weather events of 2024.
Fifteen charges under the federal Fisheries Act have been laid against Imperial Metals Corp. more than 10 years after a tailings pond collapsed the Mount Polley mine.
Many kids and teens are looking forward to the holidays with great excitement, but others find it a difficult time of year filled with anxiety, stress and loneliness. It’s something Alisa Simon, the chief youth officer at Kids Help Phone, says they watch for when school pauses for the winter break, noting, “we do see an increase...
Advocates and friends of a Nova Scotia woman who died from stage IV breast cancer are urging the province to update its screening policy for women with dense breast tissue.
The report estimates a cancer patient will face almost $33,000 on average in out-of-pocket cancer-related costs in their lifetime, including loss of income.